FMR1 and fragile X syndrome: As described above, upon establishment of the feasibility of these methods, the next crucial step would involve testing of potential treatments for the root cause of FXS and subsequent development of translational methods to measure reactivation of FMR1 mRNA and FMRP in proof of concept (POC).